Aller au contenu

A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: a UNICANCER French Sarcoma Group study (LMS03 study)

Nom du journal : Eur J Cancer

Année : 2020

Volume : 125

Page de départ : 31

Page de fin : 37

Auteurs: Delaye J, Chenuc G, Saada E, Bozec L, Pautier P, Bertucci F, Delcambre C, Bompas E, Italiano A, Guillemet C, Duffaud F, Isambert N, Piperno-Neumann S, Bay JO, Eymard JC, Cupissol D, Penel N, Rios M, Ray-Coquard I, Chevreau C,